Chemoimmuntherapie zur neoadjuvanten Behandlung des lokal fortgeschrittenen Non-Small-Cell Lung Cancer (NSCLC)
Crossref DOI link: https://doi.org/10.1007/s10405-021-00382-5
Published Online: 2021-02-17
Published Print: 2021-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Walles, Thorsten
Text and Data Mining valid from 2021-02-17
Version of Record valid from 2021-02-17
Article History
Accepted: 26 January 2021
First Online: 17 February 2021
Interessenkonflikt
: T. Walles gibt an, dass kein Interessenkonflikt besteht.